An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
Mohammad Enamul Hoque Kayesh(Kagoshima University), Kyoko Tsukiyama–Kohara(Kumamoto University), Michinori Kohara(Tokyo Metropolitan Institute of Medical Science)
Cited by 59
Related Papers
Sustainable Antibiotic-Free Broiler Meat Production: Current Trends, Challenges, and Possibilities in a Developing Country Perspective
|Biology|2020|141
Lipid nanoparticles loaded with ribonucleoprotein–oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition
|Journal of Controlled Release|2020|97
Increasing Dengue Burden and Severe Dengue Risk in Bangladesh: An Overview
|Tropical Medicine and Infectious Disease|2023|73
Hepatitis C Virus Impairs p53 via Persistent Overexpression of 3β-Hydroxysterol Δ24-Reductase
|Journal of Biological Chemistry|2009|68
Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: A multi‐institution analysis
|Journal of Gastroenterology and Hepatology|1995|60